Although Jagged1 is the third-most altered (7%) ligand of the Notch pathway after DLL3 (15%) and Jagged2 (8%) in the tumor, previous studies have identified that the omental mesothelial cells predominantly express Jagged1 [9]. Here, JAG1 is linked to neoplasm.